Pfizer, D1: Resistance zone + Side of Bollinger Bands + Hanging Man + Overbought
#PFE - 1H - MACD divergece already descounted? Notable divergence on our 1H MACD. The key question here is that if has been already discounted on the last bullish run from 31 USD to 36 USD? Today we have reach an importan resistance on 37 USD level. If there is not any news about COVID vaccine among these days, we will have a healthy correction of the price...
Hello! Friends, This would be a great short Opportunity, IF NYSE:PFE breaks down the Daily Support line at $37.05 (with a whole DAILY Candle) !!
Along with the good news about the PFE vaccine, it has increased the chances of success for this stock, and if it surpasses $ 38.5, it will confirm the "Asymmetrical Triangle" pattern. PFE buy : $38.5 PFE target : $46+-1 PFE stop loss : 10% . Current prices are supported on all 3 averages of 25-50-200. Wish you good deals!
PFE shares popped higher in response to positive virus news. The stock still has hurdles in front of it, including confluence MA resistance at $36 and critical sloped trendline pattern resistance above that in the $37.50 area.
BUY ONLY FOR THIS ONE... @PFE ESTIMATED EPS USD 0.69 - WILL BE UPDATED ON 28 JUL 2020 LAST EPS USD 0.38 LAST DIVIDEND USD 0.61
PFE continues to underperform on the long-term and under the recent fundamentals the pressure on it is growing. The Bearish Megaphone on 1D (RSI = 33.977, MACD = -1.120, ADX = 56.370) has printed a bearish continuation sequence that extends at least towards the 27.90 Support. ** If you like our free content follow our profile to get more daily ideas. **...
Buy Only for this One... @PFE Estimated EPS USD 0.69 Last EPS USD 0.61 Last Dividend USD 0.38
Buy Only for this One... @PFE Estimated Earning per Share USD 0.69 Last EPS USD 0.61 Last Dividend USD 0.38
Weekly Chart White Spinning Top Possible Morning Doji Star Reversal Symmetrical Triangle (Bearish Under 32.58) Daily Chart Symmetrical Triangle (Wide Swings) Bearish Momentum (Candlesticks Weak) Bullish Divergence RSI Consolidating since 06/11 2 Gap Fills 37.58 & 35.89 4hr Chart Falling Wedge Bullish Momentum Bullish Divergence Compressing as we get closer...
Weekly Chart White Spinning Top Possible Morning Doji Star Reversal Symmetrical Triangle (Bearish Under 32.58) Daily Chart Symmetrical Triangle (Wide Swings) Bearish Momentum (Candlesticks Weak) Bullish Divergence RSI Consolidating since 06/11 2 Gap Fills 37.58 & 35.89 4hr Chart Falling Wedge Bullish Momentum Bullish Divergence Compressing as we get...
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, such as cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; oncology, such as biologics, small molecules, immunotherapies, and biosimilars under the...
The bad news with Pfizer's clinical trial is great news for traders and investors. Why? Because the 'bottom' has been gauged by this piece of over the weekend news. The bad news does not materially affect existing revenue stream and earnings. The lack of movement intraday suggests that institutions have completely priced in the negative effect of the news...
Inverted H&S Pennant Breakout 1st Target = 786fib 2nd Target = 50 Support = 618fib @ 35 This content is for informational and educational purposes only. This is not in any way, shape or form financial or trading advice. Good luck, happy trading and stay chill, 2degreez
Pfizer was in a pretty strong uptrend for a while until it suddenly started waffling and then dumped. Wouldn't be surprised to see it pop from here, eventually. It's not exactly a fast moving stock.
🧑⚕️ Pfizer recently announced that a clinical trial of its drug Ibrance hasn't worked out as a long-term treatment for breast cancer. This news is unfortunate on a few levels, but specifically, in terms of price, the impact isn't great. Upon releasing the news PFE dumped as analyst began to revise earnings expectations downward. This sell-off caused a reversal of...
Hello investors! Today I’m going to talk about PFIZER, the only stock I own that is giving me some loss . I think it’s still worth to long it, and here’s my reasons. We see a triangle in the hourly chart, and an upwards breakout would be more desirable than a downwards because there’re less resistances than supports. Also, take a look at the daily...
If price returns to March's high, then I'll begin looking to purchase call options as close to the 36 strike as possible. These calls will expire June 1.